Shiga toxin‐producing Escherichia coli (STEC) stool multiplex PCR can replace culture for clinical diagnosis and follow‐up

Abstract

Shiga toxin (stx)‐producing Escherichia coli (STEC) causes potentially severe gastrointestinal infections. Due to its public health importance, control measures are required, and carriers may need to refrain from work or daycare when the risk of spread to vulnerable people is high. We evaluated the use of direct stool multiplex PCR compared to culture for primary STEC diagnostics and for follow‐up in order to update the national guidelines for STEC monitoring. We analyzed primary and follow‐up samples of 236 STEC PCR‐positive cases at HUSLAB, Helsinki, Finland in 2016–2017, altogether 858 samples. All STEC PCR‐positive samples were inoculated on non‐selective chromogenic agar plates. Culture positivity was confirmed from culture sweeps by PCR. 211 (89%) of the cases were culture positive in their primary sample. Of all primary and follow‐up samples, 499 were PCR positive and of these 450 (90%) were culture positive. PCR‐negative follow‐up samples were available from 125 cases. Of these, 88 cases were followed for at least three consecutive PCR‐negative samples. Two cases (2%) had culture‐positive sample(s) after two consecutive PCR‐negative samples. The median time for STEC clearance was 22–23 days. The laboratory‐developed multiplex PCR test used in this study is a reliable method for STEC diagnostics and follow‐up in a clinical laboratory. When non‐selective methodology is used, the majority of PCR‐positive samples (90%) are also culture positive. Furthermore, only two cases (2%) in our material had two consecutive PCR‐negative samples followed by positive samples. Consequently, to demonstrate the clearance from STEC infection, we consider two PCR‐negative follow‐up samples sufficient. The Finnish national guidelines for STEC monitoring have been updated accordingly.